Saxagliptin: a dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer's disease. [electronic resource]
Producer: 20140211Description: 291-300 p. digitalISSN:- 1873-7064
- Adamantane -- analogs & derivatives
- Alzheimer Disease -- chemically induced
- Amyloid beta-Peptides -- metabolism
- Animals
- Antibiotics, Antineoplastic -- toxicity
- Dipeptides -- therapeutic use
- Dipeptidyl-Peptidase IV Inhibitors -- therapeutic use
- Disease Models, Animal
- Dogs
- Dose-Response Relationship, Drug
- Exploratory Behavior -- drug effects
- Gene Expression Regulation -- drug effects
- Glucagon-Like Peptide 1 -- metabolism
- Hippocampus -- drug effects
- Interleukin-1beta -- metabolism
- Male
- Maze Learning -- drug effects
- Rats
- Rats, Wistar
- Streptozocin -- toxicity
- Tumor Necrosis Factor-alpha -- metabolism
- tau Proteins -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.